Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model.

Alzheimer's disease (AD) is a progressive neurodegenerative disease for which there are few therapeutic regimens that influence the underlying pathogenic phenotypes. However, of the currently available therapies, exercise training is considered to be one of the best candidates for amelioration of the pathological phenotypes of AD. Therefore, we directly investigated exercise training to determine whether it was able to ameliorate the molecular pathogenic phenotypes in the brain using a neuron-specific enolase (NSE)/Swedish mutation of amyloid precursor protein (APPsw) transgenic (Tg) mice as a novel AD model. To accomplish this, Non-Tg and NSE/ APPsw Tg mice were subjected to exercise on a treadmill for 16 weeks, after which their brains were evaluated to determine whether any changes in the pathological phenotype-related factors had occurred. The results indicated (i) that amyloid beta-42 (Abeta-42) peptides were significantly decreased in the NSE/APPsw Tg mice following exercise training; (ii) that exercise training inhibited the apoptotic biochemical cascades, including cytochrome c, caspase-9, caspase-3 and Bax; (iii) that the glucose transporter-1 (GLUT-1) and brain-derived neurotrophic factor (BDNF) proteins induced by exercise training protected the neurons from injury by inducing the concomitant expression of genes that encode proteins such as superoxide dismutase-1 (SOD-1), catalase and Bcl-2, which suppress oxidative stress and excitotoxic injury; (iv) that heat-shock protein-70 (HSP-70) and glucose-regulated protein-78 (GRP-78) were significantly increased in the exercise (EXE) group when compared to the sedentary (SED) group, and that these proteins may benefit the brain by making it more resistant to stress-induced neuron cell damage; (v) and that exercise training contributed to the restoration of normal levels of serum total cholesterol, insulin and glucose. Taken together, these results suggest that exercise training represents a practical therapeutic strategy for human subjects suffering from AD. Moreover, this training has the potential for use in new therapeutic strategies for the treatment of other chronic disease including diabetes, cardiovascular and Parkinson's disease.

[1]  D. Hwang,et al.  Overexpression of human selenoprotein M differentially regulates the concentrations of antioxidants and H2O2, the activity of antioxidant enzymes, and the composition of white blood cells in a transgenic rat. , 2008, International journal of molecular medicine.

[2]  C. Cotman,et al.  Three weeks of running wheel exposure improves cognitive performance in the aged Tg2576 mouse , 2007, Behavioural Brain Research.

[3]  H. Tanila,et al.  Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice , 2007, Brain Research.

[4]  Carl W. Cotman,et al.  Exercise builds brain health: key roles of growth factor cascades and inflammation , 2007, Trends in Neurosciences.

[5]  C. Netto,et al.  Effect of treadmill exercise on cell damage in rat hippocampal slices submitted to oxygen and glucose deprivation , 2007, Brain Research.

[6]  Soo‐Young Choi,et al.  Analysis of differentially expressed genes in early- and late-stage APPsw-transgenic and normal mice using cDNA microarray. , 2007, International journal of molecular medicine.

[7]  G. Taglialatela,et al.  Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotection , 2007, Neurobiology of Disease.

[8]  A. Blankenship,et al.  Cognitive and Physical Activity Differently Modulate Disease Progression in the Amyloid Precursor Protein (APP)-23 Model of Alzheimer’s Disease , 2006, Biological Psychiatry.

[9]  A. Drzezga,et al.  In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer’s disease , 2006, Angiogenesis.

[10]  M. Mattson,et al.  Ageing and neuronal vulnerability , 2006, Nature Reviews Neuroscience.

[11]  M. Scheunemann,et al.  Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice , 2006, International Journal of Developmental Neuroscience.

[12]  J. Stevens,et al.  A randomised controlled trial testing the impact of exercise on cognitive symptoms and disability of residents with dementia , 2006, Contemporary nurse.

[13]  Zhen Zheng,et al.  Antiapoptotic and Anti‐inflammatory Mechanisms of Heat‐Shock Protein Protection , 2005, Annals of the New York Academy of Sciences.

[14]  M. Mattson.  Energy intake, meal frequency, and health: a neurobiological perspective. , 2005, Annual review of nutrition.

[15]  Victoria M Perreau,et al.  Voluntary Exercise Decreases Amyloid Load in a Transgenic Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[16]  Ilana S. Hairston,et al.  Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice , 2005, Cell.

[17]  B. Christie,et al.  Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male sprague–dawley rats in vivo , 2004, Neuroscience.

[18]  Arthur F Kramer,et al.  Cardiovascular fitness and neurocognitive function in older Adults: a brief review , 2004, Brain, Behavior, and Immunity.

[19]  D. Hwang,et al.  Carboxyl-terminus of the amyloid protein precursor and ERbeta are required for estrogenic effect in activating mitogen-activated protein kinase. , 2004, International journal of molecular medicine.

[20]  S. Craft,et al.  Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. , 2004, European journal of pharmacology.

[21]  Paige E. Scalf,et al.  Cardiovascular fitness, cortical plasticity, and aging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Paik,et al.  Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw , 2004, Experimental Neurology.

[23]  F. Taneli,et al.  SERUM TESTOSTERONE, GROWTH HORMONE, AND INSULIN-LIKE GROWTH FACTOR-1 LEVELS, MENTAL REACTION TIME, AND MAXIMAL AEROBIC EXERCISE IN SEDENTARY AND LONG-TERM PHYSICALLY TRAINED ELDERLY MALES , 2004, The International journal of neuroscience.

[24]  Myoung-Hwa Lee,et al.  Treadmill exercise suppresses ischemia-induced increment in apoptosis and cell proliferation in hippocampal dentate gyrus of gerbils. , 2003, Life sciences.

[25]  A. Moraska,et al.  Habitual physical activity facilitates stress-induced HSP72 induction in brain, peripheral, and immune tissues. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[26]  Rana Noor,et al.  Superoxide dismutase--applications and relevance to human diseases. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[27]  C. Cotman,et al.  Exercise: a behavioral intervention to enhance brain health and plasticity , 2002, Trends in Neurosciences.

[28]  W. Staines,et al.  Immunohistochemical localization and quantification of glucose transporters in the mouse brain , 2002, Neuroscience.

[29]  J. Schneider,et al.  Participation in cognitively stimulating activities and risk of incident Alzheimer disease. , 2002, JAMA.

[30]  T. Ueda,et al.  The relationship between the aggregational state of the amyloid‐β peptides and free radical generation by the peptides , 2001, Journal of neurochemistry.

[31]  I. Torres-Aleman,et al.  Circulating Insulin-Like Growth Factor I Mediates Exercise-Induced Increases in the Number of New Neurons in the Adult Hippocampus , 2001, The Journal of Neuroscience.

[32]  N. Cairns,et al.  Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. , 2001, Biochemical and biophysical research communications.

[33]  E. Wanker,et al.  Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Stuart K. Calderwood,et al.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine , 2000, Nature Medicine.

[35]  H. Paulson,et al.  Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 , 1999, Nature Genetics.

[36]  B. Lu,et al.  Neurotrophins and hippocampal synaptic transmission and plasticity , 1999, Journal of neuroscience research.

[37]  W R Markesbery,et al.  The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. , 1999, The American journal of pathology.

[38]  M. Mattson,et al.  The Endoplasmic Reticulum Stress-Responsive Protein GRP78 Protects Neurons Against Excitotoxicity and Apoptosis: Suppression of Oxidative Stress and Stabilization of Calcium Homeostasis , 1999, Experimental Neurology.

[39]  A. Goate,et al.  Molecular pathogenesis of sporadic and familial forms of Alzheimer's disease. , 1998, Molecular medicine today.

[40]  G. Shah,et al.  GLUT-1 Expression in the Cerebra of Patients with Alzheimer’s Disease , 1997, Neurobiology of Aging.

[41]  K. Schmader,et al.  Weight Change in Alzheimer's Disease , 1996, Journal of the American Geriatrics Society.

[42]  E. Mufson,et al.  Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  L. Rybak,et al.  Effect of exercise training on antioxidant system in brain regions of rat , 1995, Pharmacology Biochemistry and Behavior.

[44]  C. Cotman,et al.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease , 1995, Molecular Neurobiology.

[45]  C. Cotman,et al.  Exercise and brain neurotrophins , 1995, Nature.

[46]  W. Honer,et al.  Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease , 1994, Annals of neurology.

[47]  W. Jagust,et al.  Regional cerebral glucose transport and utilization in Alzheimer's disease , 1989, Neurology.

[48]  J. Karkeck,et al.  Weight loss and senile dementia in an institutionalized elderly population. , 1989, Journal of the American Dietetic Association.

[49]  R. Morris,et al.  Place navigation impaired in rats with hippocampal lesions , 1982, Nature.

[50]  J. Wands,et al.  Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[51]  R. Vassar,et al.  Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism. , 2005, The Journal of biological chemistry.

[52]  E. Mackenzie,et al.  Akt-dependent expression of NAIP-1 protects neurons against amyloid-{beta} toxicity. , 2005, The Journal of biological chemistry.

[53]  D L Alkon,et al.  Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration. , 2005, Biochemical Society transactions.

[54]  D. Davies,et al.  Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease , 2004, Virchows Archiv.

[55]  V. Campbell,et al.  beta-Amyloid (1-40)-induced apoptosis of cultured cortical neurones involves calpain-mediated cleavage of poly-ADP-ribose polymerase. , 2003, Neurobiology of aging.

[56]  R. Holsinger,et al.  Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? , 2002, Journal of neural transmission. Supplementum.

[57]  N. Cairns,et al.  Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease. , 1999, Journal of neural transmission. Supplementum.

[58]  G. Robertson,et al.  Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. , 1999, Cell.

[59]  R. Turner,et al.  The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Abeta40 and Abeta42 secretion. , 1998, The Journal of biological chemistry.

[60]  S. Korsmeyer,et al.  Bcl-2 gene family in the nervous system. , 1997, Annual review of neuroscience.

[61]  C. Behl,et al.  Hydrogen peroxide mediates amyloid beta protein toxicity. , 1994, Cell.